DICOM PS3.3 2024d - Information Object Definitions |
---|
Table C.34.4-1 specifies the Attributes of the Clinical Trial Context Module, which identify a clinical trial context independent of any specific Clinical Trial Subjects.
Table C.34.4-1. Clinical Trial Context Module Attributes
The name of the clinical trial sponsor. See Section C.7.1.3.1.1. |
|||
Identifier for the noted protocol . See Section C.7.1.3.1.2. |
|||
The name of the clinical trial protocol .See Section C.7.1.3.1.3. |
|||
The identifier of the site responsible for submitting clinical trial data. See Section C.7.1.3.1.4. |
|||
Name of the site responsible for submitting clinical trial data. See Section C.7.1.3.1.5. |
|||
Name of the Ethics Committee or Institutional Review Board (IRB) responsible for approval of the Clinical Trial. Required if Clinical Trial Protocol Ethics Committee Approval Number (0012,0082) is present. |
|||
Approval number issued by committee described in Clinical Trial Protocol Ethics Committee Name (0012,0081). |
|||
The date the approval identified in Clinical Trial Protocol Ethics Committee Approval Number (0012,0082) becomes effective. |
|||
The date the approval identified in Clinical Trial Protocol Ethics Committee Approval Number (0012,0082) ceases to be effective. |
|||
The name of the institution that is responsible for coordinating the protocols for the clinical trial. See Section C.7.3.2.1.1. |
DICOM PS3.3 2024d - Information Object Definitions |
---|